

Gan cao, sweet root, glycyrrhiza, liquorice
Licorice, derived from the root of the plant, has been used as a flavoring and sweetening agent. This herb is also an important component of traditional Chinese medicine used to detoxify and to enhance or balance the effects of other components in herbal formulas; and as a tonic, expectorant and a demulcent in Ayurveda. A number of compounds including glycyrrhizin are thought to account for its biologic activity.
In vitro and animal data show that licorice has antibacterial (2) (27), anticancer (3) (4) (28) (29), anti-inflammatory (30) effects, and estrogenic activity (7) (8) (10). Studies also that suggest licorice can reduce cardiotoxicity associated with doxorubicin (31) and may improve efficiency of chemotherapy (32). However, these effects have not been confirmed in humans.
Licorice demonstrated effectiveness in reducing dyspepsia (1) and hyperlipidemia (33) in clinical studies.
Adverse effects of licorice include hypokalemia, hypernatremia, pseudo-hyperaldosteronism, decreased libido in men (5), and paralysis (6).
Licorice products may interfere with anticoagulants and hormonal therapy.
Flavoring agent
Licorice contains isoflavone and other constituents that have estrogen receptor modulating activities (8) (10). The flavone and liquiritigenin components selectively activate ER-alpha (11). Glycyrrhizin has been reported to bind to glucocorticoid and mineralocorticoid receptors and exerts its effect via inhibition of 11b-hydroxysteroid dehydrogenase (12). Licorice can reduce serum testosterone by inhibiting 17-hydroxysteriod dehydrogenase (35) (36). Long-term ingestion of licorice has been shown to cause secondary hypertension and hypokalemia, resulting in paralysis (6). The coumarin constituent has antiplatelet activity. Licorice has been shown to have chemopreventive effects by influencing Bcl-2/Bax (3) and via inhibiting carcinogenesis (4).
Licorice inhibited P-glycoprotein (P-gp), resulting in increased intracellular concentration of the chemo agent daunorubicin, which is a substrate of P-gp (34).
Administration of licorice after meals delays the time (Tmax) to peak concentration, but does not affect maximum concentration (Cmax) or area-under-the-curve (AUC) (13). Elimination half-life is approximately 5 hours following intravenous administration (14). Primary route of excretion is via bile (15).
Due to the adverse reaction profile of licorice, many studies have been performed using the deglycyrrhizinated licorice (DGL) extract. Deglycyrrhizinated licorice is free of glycyrrhizin and has had no reported significant adverse effects.
Licorice should not be consumed by those with renal or liver dysfunction, or women who are pregnant or breast-feeding.
Reported: Hypertension (16), lethargy, muscle pain, sodium retention, hypokalemia (17) (18) (19) (20) (26) (40) (41), adrenal crisis (21), decreased libido in men, ventricular fibrillation (22), cardiac arrythmias (23), carpal tunnel syndrome (24), glycyrrhizic acid poisoning (25), suppression of scalp sebum secretion (5), and leukoderma (42) following use of a skin lightening cream containing licorice extract have been reported.
Cardiac glycosides: Licorice may potentiate toxicity (24).
Diuretics: Chronic use of licorice may increase loss of potassium.
Spironolactone / Amiloride: Licorice should not be used simultaneously due to effects on sodium and potassium excretion.
Corticosteroids: Concomitant use with licorice might potentiate the duration of activity.
Insulin: Licorice may have a synergistic effect possibly causing hypokalemia and sodium retention with concomitant use (38) .
Hormonal therapy: Licorice may interfere with the activity of hormonal therapy due to its estrogenic or anti-estrogenic properties.
Anticoagulants: Licorice may increase the metabolism and clearance of warfarin (19).
MAO-inhibitors (MAO-I): Licorice may potentiate activity of MAO-Is.
(37) (8)
P-Glycoprotein (P-gp) substrates: Licorice inhibited P-gp, resulting in increased intracellular concentration of the chemo agent daunorubicin, which is a substrate of P-gp (34).
Cytochrome P450 substrates: Glycyrrhizin, a major ingredient of licorice, induces CYP3A and can affect the intracellular concentration of drugs metabolized by this enzyme (39).
The only studies in humans showing positive results have used deglycyrrhizinated licorice as a single agent in peptic ulcers. Studies of licorice in combination with other herbs has shown favorable results, such as PC-SPES for prostate cancer.
Madisch A, et al. Treatment of Functional Dyspepsia with a Herbal Preparation. A Double- Blind, Randomized, Placebo-Controlled, Multicenter Trial. Digestion 2004;69:45-52.
This study was aimed at determining the efficacy and safety of STW 5-II, an herbal preparation containing extracts of licorice root as one of the major ingredients as well as matricaria flower, peppermint leaves, caraway, lemon balm, and bitter candy tuft. 120 patients with functional dyspepsia were randomly assigned to 4 treatment groups and treated over a 12-week period. Patients received either STW 5-II or placebo for 8 weeks. Treatment during the last 4-week period was determined by the investigator based on symptom relief in patients. The outcome measure was the standardized gastrointestinal symptom score (GIS). There was a significant decrease in GIS in patients treated with STW 5-II compared to those on placebo during the first 4 weeks. Symptoms improved further in patients who continued treatment during the second 4 weeks. After 8 weeks, 43.3% patients on active treatment and 3.3% patients on placebo reported total symptom relief. The authors suggest that STW 5-II significantly improves symptoms of dyspepsia as compared to a placebo. However, since STW 5-II contains other herbs, the extent to which licorice contributes to relieving dyspeptic symptoms is not clear from this study.
Bottom Line: Licorice may be helpful in treating peptic ulcers, but it has not been shown effective in treating cancer.
In traditional Chinese medicine, licorice is often used in herbal formulas to harmonize the effects of other herbs. Experiments in animals and humans show licorice can mimic the effects of steroid hormones such as aldosterone and estrogen. The substance in licorice that scientists think is responsible for these effects is called glycyrrhizin. However, because glycyrrhizin causes undesirable side effects, it is often removed from licorice products during processing.
Physiologic activity has also been reported for several other compounds in licorice. Isoflavone compounds also mimic estrogens in the human body, and can kill several strains of bacteria and viruses on contact. Other compounds act as blood thinners and inhibit the process of inflammation. In humans, the compound, carbenoxolone, has been used to treat stomach and esophageal ulcers with positive effects. Scientists think that it increases blood flow to and amount of mucus lining the stomach.
Most clinical trials studying licorice have used it in combination with other herbs, such as PC-SPES for prostate cancer.
A number of clinical trials have used deglycyrrhizinated licorice to treat stomach ulcers, with favorable results.